Company profile
Hypera S.A. (Brainfarma Indústria Química e Farmacêutica S/A, wholly-owned subsidiary)
HYPE3 · B3 (Brazil) (Brainfarma is a Brazilian manufacturing subsidiary 100%-owned by Hypera S.A. (B3: HYPE3, largest Brazilian pharma company by market cap, listed on Novo Mercado since 2008); resolving the subsidiary to its investor-relevant, publicly-traded parent. Not currently on our roster. Sources: https://clinicaltrials.gov/study/NCT07712913 ; https://ri.hypera.com.br/en/hypera-pharma/corporate-profile/ ; https://stockanalysis.com/quote/bvmf/HYPE3/company/ Entity resolved by asset-pipeline-v2.)
Public Market Listing
Live quotes, historical charts, and market capitalization for Hypera S.A. (Brainfarma Indústria Química e Farmacêutica S/A, wholly-owned subsidiary) are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(1 total)
| Target & Modality | |||
|---|---|---|---|
| Approved | α2δ subunit of voltage-gated calcium channelsSmall molecule | EpilepsyDiabetic Peripheral Neuropathic Pain |
Upcoming events
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.